BrosMed Wechat Account
04.03.2025
In early March 2025, BrosMed Medical announced the market approval of its self-developed Khons Kangzhuo™ Guidewire (Guangdong Medical Device Registration No. 20252030334). This product is indicated for guiding catheter insertion and positioning in interventional diagnostic/therapeutic procedures (excluding neurovascular applications). With excellent support performance and near 1:1 precise torque control as core advantages, it aims to enhance efficiency and safety in peripheral vascular interventions, empowering clinicians to address complex vascular lesions.
Disclaimer
Investment Involves risk. Past performance does not represent future performance. Investor should read the product’s Prospectus for details and risk factors before making investment decision. The contents of this website is prepared and maintained by Mirae Asset Capital (China) Limited. This material has not been reviewed by the Securities and Futures Commission. Certain information contained in this website is compiled from third party sources. Whilst we have, to the best of its endeavor, ensured that such, information is accurate, complete and up-to-date, and has taken care in accurately reproducing the information. We accepts no liability for, any loss or damage of any kind resulting out of the unauthorized use of this website.
Sep 28, 2025
